Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers Without Charcoal Block

Conditions:   Asthma;   Chronic Obstructive Pulmonary Disease (COPD)
Interventions:   Drug: Fluticasone propionate;   Drug: Salmeterol (as xinafoate)
Sponsor:   Intech Biopharm Ltd.
Completed – verified June 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days